Business Description
Renalytix PLC
ISIN : US75973T1016
Share Class Description:
RNLXY: ADRDescription
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | -2.36 | |||||
| Debt-to-Equity | -0.73 | |||||
| Debt-to-EBITDA | -0.34 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -83.81 | |||||
| Beneish M-Score | -6.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.3 | |||||
| 3-Year EBITDA Growth Rate | 14.9 | |||||
| 3-Year EPS without NRI Growth Rate | 15.8 | |||||
| 3-Year FCF Growth Rate | 5.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 80.8 | |||||
| 9-Day RSI | 75.65 | |||||
| 14-Day RSI | 68.85 | |||||
| 6-1 Month Momentum % | -64.81 | |||||
| 12-1 Month Momentum % | -62.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.24 | |||||
| Quick Ratio | 0.24 | |||||
| Cash Ratio | 0.08 | |||||
| Days Inventory | 112.25 | |||||
| Days Sales Outstanding | 142.5 | |||||
| Days Payable | 704.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.8 | |||||
| Shareholder Yield % | -24.22 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 13.88 | |||||
| Operating Margin % | -1054.16 | |||||
| Net Margin % | -1221.67 | |||||
| FCF Margin % | -1039.24 | |||||
| ROA % | -225.05 | |||||
| ROIC % | -176.36 | |||||
| ROC (Joel Greenblatt) % | -5061.42 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.86 | |||||
| EV-to-EBIT | -1.87 | |||||
| EV-to-Forward-EBIT | -1.58 | |||||
| EV-to-EBITDA | -1.97 | |||||
| EV-to-Forward-EBITDA | -1.68 | |||||
| EV-to-Revenue | 19.76 | |||||
| EV-to-Forward-Revenue | 1.74 | |||||
| EV-to-FCF | -1.9 | |||||
| Earnings Yield (Greenblatt) % | -53.48 | |||||
| FCF Yield % | -57.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RNLXY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Renalytix PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.352 | ||
| EPS (TTM) ($) | -0.503 | ||
| Beta | 3 | ||
| Volatility % | 310.92 | ||
| 14-Day RSI | 68.85 | ||
| 14-Day ATR ($) | 0.02154 | ||
| 20-Day SMA ($) | 0.165762 | ||
| 12-1 Month Momentum % | -62.24 | ||
| 52-Week Range ($) | 0.12 - 2.4 | ||
| Shares Outstanding (Mil) | 166.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Renalytix PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Renalytix PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Renalytix PLC Frequently Asked Questions
What is Renalytix PLC(RNLXY)'s stock price today?
The current price of RNLXY is $0.21. The 52 week high of RNLXY is $2.40 and 52 week low is $0.12.
When is next earnings date of Renalytix PLC(RNLXY)?
The next earnings date of Renalytix PLC(RNLXY) is 2025-02-14 Est..
Does Renalytix PLC(RNLXY) pay dividends? If so, how much?
Renalytix PLC(RNLXY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers